TY - JOUR
T1 - Three Decades of Dementia Research
T2 - Insights from One Small Community of Indomitable Rotterdammers
AU - Wolters, Frank J.
AU - Adams, Hieab H.H.
AU - Bos, Daniel
AU - Licher, Silvan
AU - Ikram, M. Arfan
N1 - Funding Information:
In conclusion, for nearly 30 years now the Rotterdam Study has contributed greatly to the understanding of dementia, in terms of incidence, risk factors, pathobiology, and prognosis. It achieved its success through exploring novel underlying The authors are grateful to the study participants, the staff from the Rotterdam Study, the participating general practitioners and pharmacists, and acknowledge the support of Frank J. A. van Rooij as data manager. The Rotterdam Study is sponsored by the Erasmus Medical Centre and Erasmus University Rotterdam, The Netherlands Organization for Scientific Research (NWO), The Netherlands Organization for Health Research and Development (ZonMW), the Research Institute for Diseases in the Elderly (RIDE), The Netherlands Genomics Initiative, the Ministry of Education, Culture and Science, the Ministry of Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. Further support was obtained from the Netherlands Consortium for Healthy Ageing and the Dutch Heart Foundation (2012T008), the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (project: ORACLE, grant agreement No: 678543), the Joint Programme—Neurodegenerative Disease Research working groups on High-Dimensional Research in Alzheimer’s Disease (ZonMW grant number 733051031) and Full exploitation of High Dimensionality (ZonMW grant number 733051032). None of the funding organizations or sponsors were involved in study design, in collection, analysis, and interpretation of data, in writing of the report, or in the decision to submit the article for publication.
Publisher Copyright:
© 2018 - IOS Press and the authors. All rights reserved.
PY - 2018
Y1 - 2018
N2 - The most commonly encountered opening sentence in scientific publications about dementia undoubtedly relates to the overwhelming burden of disease. Finding an effective preventive or therapeutic intervention against dementia has been considered the most important unmet need in contemporary medicine. While efforts on tackling this devastating disease have increased exponentially, it is difficult to imagine that in the 1980s and early-1990s, the disease did not feature prominently on any public health report. Yet, it was already then that epidemiologists recognized the growing societal burden of dementia and rationalized that dementia is not necessarily part of aging. Indeed, the conviction that dementia is pathologically distinct from aging led to various efforts in search of unravelling its risk factors and understanding its pre-clinical phase. Among the early pioneers, the population-based Rotterdam Study was initiated in 1990 clearly aiming on chronic diseases including dementia, and among this Alzheimer's disease, as one of its focus points. Ever since, the Rotterdam Study has been an important cornerstone in increasing our knowledge about dementia from an epidemiological perspective. Here, we summarize the main findings originating from this study, and put these into perspective with previous and current work in the field. With an expanding scope of the Rotterdam Study over the years, we discuss findings on occurrence, modifiable risk factors, imaging, and its genetic underpinnings. Importantly, we conclude with recommendations -or, perhaps better stated, a wish list -for future research which may help us reach our finish line: finding an effective preventive or therapeutic intervention against dementia.
AB - The most commonly encountered opening sentence in scientific publications about dementia undoubtedly relates to the overwhelming burden of disease. Finding an effective preventive or therapeutic intervention against dementia has been considered the most important unmet need in contemporary medicine. While efforts on tackling this devastating disease have increased exponentially, it is difficult to imagine that in the 1980s and early-1990s, the disease did not feature prominently on any public health report. Yet, it was already then that epidemiologists recognized the growing societal burden of dementia and rationalized that dementia is not necessarily part of aging. Indeed, the conviction that dementia is pathologically distinct from aging led to various efforts in search of unravelling its risk factors and understanding its pre-clinical phase. Among the early pioneers, the population-based Rotterdam Study was initiated in 1990 clearly aiming on chronic diseases including dementia, and among this Alzheimer's disease, as one of its focus points. Ever since, the Rotterdam Study has been an important cornerstone in increasing our knowledge about dementia from an epidemiological perspective. Here, we summarize the main findings originating from this study, and put these into perspective with previous and current work in the field. With an expanding scope of the Rotterdam Study over the years, we discuss findings on occurrence, modifiable risk factors, imaging, and its genetic underpinnings. Importantly, we conclude with recommendations -or, perhaps better stated, a wish list -for future research which may help us reach our finish line: finding an effective preventive or therapeutic intervention against dementia.
KW - Alzheimer's disease
KW - cohort studies
KW - dementia
KW - epidemiologic methods
KW - epidemiology
KW - neurodegenerative diseases
UR - http://www.scopus.com/inward/record.url?scp=85048598924&partnerID=8YFLogxK
U2 - 10.3233/JAD-179938
DO - 10.3233/JAD-179938
M3 - Review article
C2 - 29843240
AN - SCOPUS:85048598924
SN - 1387-2877
VL - 64
SP - S145-S159
JO - Journal of Alzheimer's Disease
JF - Journal of Alzheimer's Disease
IS - s1
ER -